Rocket Lab — Blitz Index 62 (B)

The R&D blitz — near-zero debt, a $2.36B backlog, and a rocket that has not flown yet.

Score breakdown

Radar axes (0–100): Moat 57 · Speed 76 · Creative 67.

Watch item

Gates: G1 pass · G2 pass (estimated). 3 below threshold — first-ever score.

Strengths

• Organic growth ~+52% with acquired revenue stripped (SEC)
• Backlog $2.36B (+137%) + 90+ launches — largest ever (SEC)
• Gross margin improving (34.4% → 36.1%), non-GAAP 41.5% (SEC)
• Near-zero debt + $2.13B cash — funding risk far below neoclouds

Concerns

• Launch revenue stalling (−4.4% YoY) — Neutron must answer
• Neutron unflown — key B2 variable still unproven
• Ongoing dilution: ATM $1.94B, Iridium deal adds shares
• Launch contracts have customer termination rights — weaker lock-in than take-or-pay

Research notes

1. Current Position — Late Act 1 of the R&D Blitz (Just Before the Efficiency Turn)

Rocket Lab is in the **latter half of blitz Act 1**. Q2 2026 revenue of $234.1M (+62.0% YoY, SEC confirmed), Q1 of $200.3M (+63.5%, SEC confirmed) — continuing FY2025's $601.8M (+38.0%) and FY2024's $436.2M (+78.4%): three consecutive years of high growth. Excluding the acquisition contribution (Mynaric $13.2M + Motiv $1.4M, Q2·SEC), **organic growth ≈ +52%** — growing at near-doubling speed even without acquisitions is the core of its substance. A backlog of $2.36B (+137% YoY, SEC 8-K), a launch backlog of 90+ launches (all-time high), and Q3 guidance of $250–265M (consecutive record, SEC 8-K) prove "the density of contracts."

2. Blitzscaling Lens

**Rule 8. "Raise Too Much Money" — but with "stock," not "debt."** RKLB is the hardware variant of Rule 8. If CRWV executed Rule 8 by "raising too much debt" (total debt $35B+ = ~4.6x TTM revenue, D1 −8), RKLB executes it by **"printing too many shares."** H1 ATM $1.53B (SEC) → September ATM $1.94B (press-reported) — debt was deliberately excluded to the point of closing and terminating a $3.6B bridge loan (press-reported). Capital access itself is top-tier (A2 4 points).

3. Competitive Landscape — SpaceX as the Dominant Order, and the Frontier Batch

**The structural competitor is SpaceX** — and the legacy primes. As the score file organizes it, RKLB's C1 (displaced order) 4 points reflects the "end-to-end space company" (design-manufacture-launch-operate) model displacing legacy primes like ULA·Arianespace and the parts supply chain. Batch launch+satellite orders (one of 2 SB-AMTI companies) are the evidence of the structural inversion. But the dominant order called SpaceX remains — Electron is No. 2 globally in the dedicated small-launch market, effectively the leader (press-reported), yet SpaceX rules medium class and above. That is why C1 is tied with NBIS (4 points) — the displaced order is the legacy primes, not SpaceX. Through Ledger perspective ③ ("the real threat is fratricide"), the post-Neutron-success landscape becomes the collision with SpaceX in the medium-class market.

4. Inflection Points

**Inflection Point 1. Neutron's pad delivery and maiden flight — the point that is everything.** What to watch: whether the Q4 2026 pad-delivery target (Stage 1 tank, aligned in SEC 8-K) is met, and the timing and outcome of the maiden flight. Only Neutron can break the Launch segment's −4.4% YoY (SEC) stagnation. It is the key variable of B2 (11 points) and the simultaneous upside trigger for B3·C3 — on success, the "R&D blitz's" upfront investment converts to proof. On delay, the launch segment's stagnation structuralizes, and the single Space Systems growth structure caps the score. Link: RKLB is not included in the earnings calendar's 21-company lineup — the first post-T earnings (expected 11/9) is the observation point. But Neutron's fate must be observed as program milestones, not quarterly results. Before v1.1 candidate 1 ("A2 measurement of the R&D-type blitz") is formalized, the fuel structure of the "developing blitz" — H1 capex of $53M vs R&D of $163M (SEC) — is not directly reflected in the score — v1.0's blind spot, and the reason 62/B describes a thesis still "in flight."

5. One-Line Risk

The time bought with dilution (Neutron) and the business bought without debt (Iridium) — if both equity-blitz bets run late, the denominator (share count) remains while the numerator (revenue) bends; that is this company's fundamental risk.

1. Current Position — Late Act 1 of the R&D Blitz (Just Before the Efficiency Turn)

Rocket Lab is in the **latter half of blitz Act 1**. Q2 2026 revenue of $234.1M (+62.0% YoY, SEC confirmed), Q1 of $200.3M (+63.5%, SEC confirmed) — continuing FY2025's $601.8M (+38.0%) and FY2024's $436.2M (+78.4%): three consecutive years of high growth. Excluding the acquisition contribution (Mynaric $13.2M + Motiv $1.4M, Q2·SEC), **organic growth ≈ +52%** — growing at near-doubling speed even without acquisitions is the core of its substance. A backlog of $2.36B (+137% YoY, SEC 8-K), a launch backlog of 90+ launches (all-time high), and Q3 guidance of $250–265M (consecutive record, SEC 8-K) prove "the density of contracts."

And yet the score is 62/B, 3 points below the threshold — the opposite of CRWV, where financing quality dragged down business quality — because here the business is healthy but the blitz's price is buried in **capital structure** rather than the balance sheet. RKLB is the rare case of "blitzing without debt." Total debt of $695M vs equity of $3.49B (6/30, SEC confirmed), quarterly interest expense of $0.58M vs interest income of $16.5M — a blitz where **interest income is 28x interest expense**. D1 0 points is the lightest deduction among 36 scored companies. But the price is dilution. Weighted-average shares 515M → 630M (SEC), H1 ATM of $1.53B (SEC) + September ATM of $1.94B (29.3M shares, press-reported) — roughly 8% of market cap printed in a year. If neoclouds "build with borrowed money," RKLB **"builds with printed shares"** — that is the 62/B thesis.

**GATE verdict:** G1 (sustained growth or a second growth curve) PASS (confirmed) — Q2 +62.0% YoY, organic growth ≈ +52%, and consecutive-record Q3 guidance are the evidence. G2 (new markets' 10-year ceiling ≥ 10x current revenue, bar ≈ $7.7B) PASS (estimate) — the combined addressable market of launch · satellite manufacturing · satellite-communications services (industry estimates, press-reported) far exceeds the bar. But the $2.36B backlog alone is only ~30% of the bar — unlike NBIS (contracts alone 3x the bar), this pass leans on TAM estimates rather than contracts, which is B3's (8 points) limit.

**The dual structure of growth:** the segments say what the business is most precisely. Space Systems at $189.5M per quarter (+93.6% YoY) vs Launch at −4.4% (stagnant) — SEC confirmed. The company known as a "rocket company" is actually growing in satellites and systems. Electron's cadence is an operational moat, but the small class's structural limit must be solved by Neutron. That is why all of this company's risks converge on one place (Neutron).

**Two-sided assessment (per the score file):** - **On the upside:** Organic growth ≈ +52% (Q2, SEC) · backlog of $2.36B (+137% YoY) + 90+ launch backlog (SEC) · Q3 guidance of $250–265M + adjusted EBITDA loss of −$17~−$23M (approaching breakeven, SEC) · improving gross-margin trend (FY2025 34.4% → Q2 36.1%, Non-GAAP 41.5%, SEC) · effectively debt-free + cash $2.13B (financing risk markedly lower than neoclouds) · Iridium acquisition (EV ~$8B, shareholder approval completed 9/24 — the structural business transition via recurring-revenue satellite communications, press-reported) · Space Force $397M Flatellite + $160M+ geostationary satellites (structural validation of defense demand, SEC). - **On the downside:** Launch segment revenue stagnant (−4.4% YoY — Electron's cadence limit; Neutron must be the answer) · Neutron unflown (B2's key variable still unproven, Q4 2026 pad-delivery target — SEC 8-K) · ongoing dilution (shares 515M → 630M, September ATM $1.94B additional, additional Iridium-deal issuance — collar $67.50–$112.50, press-reported) · Iridium integration risk (EV ~$8B = ~20% of market cap, closing mid-2027 — press-reported) · customers' termination rights on launch contracts (stated in the 10-K; weaker lock-in than neocloud take-or-pay) · the shadow of acquisition-driven growth (Mynaric·Motiv·GEOST·Iridium — organic vs acquisition growth must be distinguished) · P/S ~53x (not reflected in the score).

The directional assessment is **"rising (execution sprint)"** — the direction depends on three points: Neutron's pad delivery and maiden flight, Iridium integration execution, and whether the speed of "printed shares" outruns the speed of "recognized revenue." 62/B is the boundary case, 3 points below the threshold — one upward trigger crosses it.

2. Blitzscaling Lens

**Rule 8. "Raise Too Much Money" — but with "stock," not "debt."** RKLB is the hardware variant of Rule 8. If CRWV executed Rule 8 by "raising too much debt" (total debt $35B+ = ~4.6x TTM revenue, D1 −8), RKLB executes it by **"printing too many shares."** H1 ATM $1.53B (SEC) → September ATM $1.94B (press-reported) — debt was deliberately excluded to the point of closing and terminating a $3.6B bridge loan (press-reported). Capital access itself is top-tier (A2 4 points).

Both executed Rule 8, but **the money is of different quality, and so the score's structure differs** (CRWV 55/C vs RKLB 62/B, exactly 7 points apart — of which the D1 −8 vs 0 difference is the core). The score file's v1.1 candidate 1 ("distinguishing contract-backed project financing from debt-market-dependent financing") was CRWV·IREN's variant; RKLB adds a third axis on top of that distinction — **the "equity blitz."** Debt interest ticks every quarter like a clock (D1 −8's warning); share dilution remains in the stock price's denominator. Which price is heavier, Neutron and Iridium will prove. Rule 8 said "raise too much money" — it did not price the money.

**The limits of Rule 4 — rockets cannot be patched like software.** Blitzscaling says "launch an embarrassing product and patch it" (Rule 4), but **an orbital-class rocket cannot be patched like software**. The fundamental grammar of "heavy-equipment blitzscaling" shared with the CRWV research. Electron is already a proven product with 18 launches per year of cadence (2026, press-reported) and a 1,700+ mission flight heritage. But the next engine, Neutron, is only "aligned" with the Q4 2026 pad-delivery target for the Stage 1 tank (SEC 8-K) — **unflown**.

On applicability conditions, too, RKLB is a variant. Of the prerequisites — "a business model where the rewards of speed are large in network effects, virality, or data advantage" — RKLB does not have true demand-side network effects (B1 7 points — "no true demand-side network effects"). The winner-take-all reward lies in supply-side and institutional moats — defense certifications, flight heritage, vertical integration — and in preempting launch cadence as the "space era's distribution network." The five-growth-lever verdict (score file) — primary lever distribution (launch capability) + capital, secondary lever vertical integration, weak lever network effects — is the declaration of the "R&D blitz." But unlike the software blitz, here the failure of "launching an unfinished product" is not one quarter's disappointment but years of lost development time. That is why RKLB chose the path of printing "embarrassing share counts" instead of launching "embarrassing products" — a structure that fills Rule 4's absence with Rule 8.

**Rule 5. "Let It Burn" — this company's big fire is one thing: Neutron.** Hoffman's fire priority is "extinguish only the fires that can kill the company; let the small ones burn." For RKLB the true big fire is **Neutron's maiden flight** — the key variable of B2 (distribution scalability) 11 points. Launch revenue is already stagnant at −4.4% YoY (SEC) — Electron's cadence limit is not a problem operational efficiency can solve; only a different product, a medium-class rocket, can solve it. Space Systems +93.6% is pulling overall growth, but "the rocket company's" identity keeps B3·C3 capped as long as the launch segment stagnates.

If Neutron succeeds, B2·B3·C3 (the reusability bet) open simultaneously — in the score file's words, this company's score is a bet on Neutron's score. Meanwhile the small fires are the dilution controversy and founder concentration (D3 −1). Beck's CEO+President+Chairman concentration is a founder-concentrated structure, but no confirmed conflicts of interest or insider-selling issues (no press-reported confirmation). No confirmed litigation or regulatory issues (D4 0). A company with few small fires — the reason for the lightest deduction structure among 36 companies at D −1. But few small fires does not make the big fire small. If Neutron delays and Iridium integration struggles overlap, the worst combination arrives: dilution remains while growth bends.

3. Competitive Landscape — SpaceX as the Dominant Order, and the Frontier Batch

**The structural competitor is SpaceX** — and the legacy primes. As the score file organizes it, RKLB's C1 (displaced order) 4 points reflects the "end-to-end space company" (design-manufacture-launch-operate) model displacing legacy primes like ULA·Arianespace and the parts supply chain. Batch launch+satellite orders (one of 2 SB-AMTI companies) are the evidence of the structural inversion. But the dominant order called SpaceX remains — Electron is No. 2 globally in the dedicated small-launch market, effectively the leader (press-reported), yet SpaceX rules medium class and above. That is why C1 is tied with NBIS (4 points) — the displaced order is the legacy primes, not SpaceX. Through Ledger perspective ③ ("the real threat is fratricide"), the post-Neutron-success landscape becomes the collision with SpaceX in the medium-class market.

**The Iridium acquisition moves the competitive coordinates themselves.** If the EV ~$8B acquisition closes (expected mid-2027, press-reported), RKLB transitions its identity from "launch operator" to "vertically integrated space power" (SEC 8-K). The inclusion of recurring-revenue satellite-communications business expands the competitive landscape from launch-market cadence competition to satellite-communications ARPU competition. The extension of vertical-integration acquisitions — Mynaric (optical, $161M in stock)·Motiv (robotics, $45M)·GEOST ($275M) (SEC confirmed) — the culmination of a "parts preemption" strategy answering the neoclouds' "power preemption."

**The frontier batch coordinates** are this research's core contrast axis. The memo's prospect ranking (RKLB > ASTS > SYM > IONQ) matches our scores (RKLB 63 > SYM 54 > ASTS 51 > IONQ 47) at ranks 1 and 4, with the middle inverted. As the score file records, the difference's cause is the standard difference — the memo ranking sees "option value (upside)"; our score sees "recognized substance." ASTS has the largest asymmetric upside but is pre-commercial-revenue (our score 51/C); SYM has the highest backlog visibility but is close to the efficiency stage, making it feel less like a "pure blitz" (our score 54/B) — not a contradiction but a different question. That RKLB ranks first under both standards is this batch's most robust fact.

**The direction of creative destruction:** C2 (irreversible behavioral change) 3 points — the 90+ launch backlog + satellite design-in + government program lock-in. But the 10-K states: launch contracts carry customers' termination rights (subject to penalty terms) — not take-or-pay. This is the decisive difference scored 1 point lower than NBIS (4 points), and the basis of v1.1 candidate 3 ("C2 sub-segmentation of terminable contracts"). Contract liabilities of $351M (prepayments, SEC) count as partial lock-in. C3 (cost-structure change) 3 points — falling per-launch costs from scale efficiencies (10-K "efficiencies of scale," SEC), with Neutron reusability as the cost-structure-collapse bet — but unflown, so unproven.

4. Inflection Points

**Inflection Point 1. Neutron's pad delivery and maiden flight — the point that is everything.** What to watch: whether the Q4 2026 pad-delivery target (Stage 1 tank, aligned in SEC 8-K) is met, and the timing and outcome of the maiden flight. Only Neutron can break the Launch segment's −4.4% YoY (SEC) stagnation. It is the key variable of B2 (11 points) and the simultaneous upside trigger for B3·C3 — on success, the "R&D blitz's" upfront investment converts to proof. On delay, the launch segment's stagnation structuralizes, and the single Space Systems growth structure caps the score. Link: RKLB is not included in the earnings calendar's 21-company lineup — the first post-T earnings (expected 11/9) is the observation point. But Neutron's fate must be observed as program milestones, not quarterly results. Before v1.1 candidate 1 ("A2 measurement of the R&D-type blitz") is formalized, the fuel structure of the "developing blitz" — H1 capex of $53M vs R&D of $163M (SEC) — is not directly reflected in the score — v1.0's blind spot, and the reason 62/B describes a thesis still "in flight."

**Inflection Point 2. Iridium integration — from "launch operator" to "vertically integrated space power."** What to watch: after closing (expected mid-2027, press-reported), when and in what structure Iridium's recurring revenue reflects in consolidated revenue. EV ~$8B is ~20% of market cap (press-reported) — a failed acquisition hits hard, and a successful one transforms big. The Iridium debt (~$1.8B, press-reported) consolidates after closing — whether the "debt-free blitz" narrative of D1 0 points holds, and whether the speed of dilution outruns the speed of merger synergies are the observation points. The collar of $67.50–$112.50 (press-reported) also defines dilution's floor. Link: if "recurring-revenue telecom business" as demand-side stability joins B1's (7 points) institutional moat (defense certifications, flight heritage), the C1 4-point "identity transition" narrative is backed by measurement. Conversely, if integration struggles overlap with Neutron delays, the worst combination arrives: dilution remains while growth bends — the moment one of the score file's maximum risks becomes real.

**Inflection Point 3. Dilution speed vs recognized-revenue speed — the breakeven of the equity blitz.** What to watch: the race between quarterly weighted-average share growth (515M → 630M, SEC) and quarterly revenue growth (+62.0% YoY, SEC). Whether further financing announcements continue after the September ATM of $1.94B (press-reported), and whether per-share revenue (dilution-adjusted) actually trends upward. When the Iridium deal's additional issuance begins, the second wave of dilution arrives. If revenue wins this race, the "speed bought with shares" is justified; if dilution wins, the 62/B thesis itself wobbles. Link: D1 0 points means "no debt," not "free capital." Revenue per employee of ~$296K (computed) — 1/10 of CRWV's (~$3.5M) — is the structural trait of hardware/manufacturing-intensive business, but the "growing while earning" narrative (improving gross margin, adjusted EBITDA −3.8% approaching breakeven) must be proven in per-share metrics for dilution's price to be offset. P/S ~53x (press-reported, not reflected in the score) warns that a second-blitz failure would hit hard — the point where the price the market sees meets the business score that ignores price is exactly this inflection point.

**Observation checklist (quarterly):** ① whether quarterly revenue hits guidance ($250–265M, SEC) and organic growth (ex-acquisitions) holds ② Neutron pad-delivery · maiden-flight milestones ③ the Space Systems vs Launch segment growth gap (+93.6% vs −4.4%, SEC) ④ the gross-margin improvement trend (34.4% → 36.1%, Non-GAAP 41.5%) and adjusted-EBITDA breakeven (−3.8% → 0%) ⑤ weighted-average share growth speed vs revenue growth ⑥ Iridium deal closing (expected mid-2027) and integration progress. ①·③·④ are "execution" metrics, ② is a "bet" metric, ⑤·⑥ are "structure" metrics. If execution metrics trend up and Neutron flies, 62/B rises toward the "R&D blitz's climax" direction. If Neutron delays + Iridium integration struggles + dilution acceleration overlap, the equity blitz's price remains while the growth engine stops — in the heavy blitz, one program's delay carries a different weight than one quarter's miss at a software company.

5. One-Line Risk

The time bought with dilution (Neutron) and the business bought without debt (Iridium) — if both equity-blitz bets run late, the denominator (share count) remains while the numerator (revenue) bends; that is this company's fundamental risk.

*BlitzLab v1.0 (frozen). Unconfirmed figures must be labeled estimate / press-reported.* *For education and research purposes only. Not a recommendation to buy, sell, or hold any security.*

### Verification Log - Verification review waived.

*Translated from the Korean edition (2026-10-15). For education and research purposes only. Not a recommendation to buy, sell, or hold any security.*

Next earnings

Nov 9, 2026 · After close · Expected

Coverage

As of October 2026 · Model v1.0 (frozen) · Confidence: High (listed, SEC filings) · Not investment advice — a scholar's assessment.

BlitzLab scores businesses against a scholar’s standard — not investment advice. No price targets, no buy/sell recommendations. Figures are from SEC filings (XBRL) as labeled in the source scorecard.